4//SEC Filing
dEsparbes Eric 4
Accession 0000899243-23-009032
CIK 0001580063other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 9:16 PM ET
Size
8.5 KB
Accession
0000899243-23-009032
Insider Transaction Report
Form 4
dEsparbes Eric
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-15+62,225→ 90,365 total - Award
Common Stock
2023-03-15+22,692→ 113,057 total - Tax Payment
Common Stock
2023-03-15$2.56/sh−11,216$28,713→ 101,841 total
Footnotes (3)
- [F1]Consists of 62,225 restricted stock units ("RSUs"), 25% of which will vest on May 15, 2024, with the remaining shares vesting in equal semi-annual installments through May 15, 2027, subject to the Reporting Person's continued service to the Issuer.
- [F2]Consists of 22,692 RSUs, which vested upon grant.
- [F3]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.
Documents
Issuer
BIORA THERAPEUTICS, INC.
CIK 0001580063
Entity typeother
Related Parties
1- filerCIK 0001622268
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 9:16 PM ET
- Size
- 8.5 KB